Transcatheter Embolization And Occlusion Devices Market To Reach $8.54 Billion By 2030

Transcatheter Embolization And Occlusion Devices Market Growth & Trends

The global transcatheter embolization and occlusion devices market size is estimated to reach USD 8.54 billion by 2030, registering a CAGR of 7.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. Key drivers of the TEO devices market include increasing adoption of minimally invasive surgeries and rising prevalence of cancer.

In addition, wide usage of embolization technique as a treatment for conditions other than cancer, such as vascular malformations and fibrosis, is fueling the demand for TEO devices globally. Furthermore, introduction of technically advanced products with enhanced efficiency is supporting the global market growth. On the other hand, high cost, stringent regulatory approval procedures, and requirement of experienced healthcare professionals to perform TEO procedures are some of the factors that may have a negative impact on the market development.

Asia Pacific TEO devices market is anticipated to witness highest CAGR, due to increasing healthcare expenditure and improving healthcare infrastructure. Rapid expansion of medical tourism industry in the emerging countries of APAC is also boosting the demand for TEO devices.

 Request a free sample copy or view report summary: Transcatheter Embolization And Occlusion Devices Market Report

Transcatheter Embolization And Occlusion Devices Market Report Highlights

• In 2024, The non-coil product segment dominated the market with the largest revenue share of 52.3%, propelled by its versatility and effectiveness in a wide range of clinical applications.

• Based product, the coil segment is anticipated to grow at a significant CAGR of 7.0% over the forecast period, driven by its growing application in treating various vascular conditions.

• North America dominated the global market with the largest revenue share of 36.6% in 2024, attributed to the increased adoption of Interventional Radiology (IR) procedures.

Transcatheter Embolization And Occlusion Devices Market Segmentation

Grand View Research has segmented the global transcatheter embolization and occlusion devices market on the basis of product, and region:

Transcatheter Embolization & Occlusion Devices Product Outlook (Revenue, USD Million, 2018 - 2030)

• Coil

  • Pushable Coils

  • Detachable Coils

• Non Coil

  • Flow Diverting Devices

  • Embolization Particles

  • Liquid Embolics

  • Other Embolization and Occlusion Devices

  • Accessories

Transcatheter Embolization & Occlusion Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Transcatheter Embolization And Occlusion Devices Market

• Boston Scientific Corporation

• Terumo Corporation

• Medtronic

• DePuy Synthes (Johnson & Johnson)

• Stryker

• Cordis

• Abbott

• Pfizer Inc.

• Sirtex SIR-Spheres Pty Ltd.

• Nordion (Canada) Inc.